A genome is a full collection of DNA that contains all of an individual's genes. Genomic science is the study of an organism's genome with an emphasis on its evolution, structure, and function.
It’s being expected that by 2029, the Artificial Intelligence In Genomics market cap will hit $6.22 billion at a CAGR growth of about 42.8%.
COVID-19 Impact on the global Artificial Intelligence in Genomics Market:
The global outbreak of COVID-19 brought about an ongoing downturn withinside the healthcare market. Apart from communities, COVID-19 became similarly disastrous for significant international economies, particularly the healthcare sector. Prominent stakeholders are persevering to conform their techniques to the hastily converting situation. On the healthcare industry, COVID-19 is expected to produce long-term full-size period impacts. Countries and significant gamers ought to adopt vital healthcare adjustments until the disaster takes a returned seat.
Pharmaceutical and biotech firms held the highest proportion of the global artificial intelligence market in genomics in 2019.
Data is an essential element of drug companies for drug development, proving their safety and effectiveness. Therefore, AI helps to analyze this data efficiently and securely.
Rising rates of diseases such as cancer and genetic disorders and the growing need to reduce drug development time and costs are likely to support the growth of this segment, the authors state.
In 2019, the global artificial intelligence market in genomics was dominated by the technology-driven machine learning segment.
Because genomics generates a lot of data, most bioinformatics algorithms rely on machine learning to find patterns and make predictions.
In addition, pharmaceutical and biotech companies are increasingly applying machine learning to pharmaceutical genomics applications as it extracts meaningful insights from data sets and enhances genomics research.
North America has the highest share of the global artificial intelligence in genomics market in 2020
The region was dominated owing to the increasing investment across the region, it will hold this position during the projected period. For research and development, as well as important government efforts to enhance precision medicine in the region.
In addition, the presence of key players, the development of infrastructure to support cutting-edge technology, and the incredible strategies of the market players to deliver effective solutions bring development opportunities for Artificial Intelligence in the genetics market.
Artificial intelligence's involvement in the genome is now to assist in the development of medications to treat uncommon disorders.
Artificial intelligence (AI) is utilised in genomics to construct computer systems that can do tasks like genome mapping. Furthermore, AI is helpful in the faster investigation of genetic material structure, evolution, and function than is achievable with human contact. Despite the fact that AI algorithms are utilised in clinical genomics to undertake genome analysis such as genome annotation, phenotype-genotype matching, variant calling, and genome annotation, their primary goal is to imitate human intelligence. Furthermore, AI approaches can assist in the prediction of protein structure or DNA data with minimum manual input. In the field of personalised medicine, genomics applications are critical. AI can aid in the production of drugs in this sector.
according to the Global Artificial Intelligence in Genomics Market Analysis. The market's growth is mainly driven by the growing demand in analyzing patient data using AI to discover new methods to improve the overall quality of healthcare.
Technological progress, value containment, and improved get admission are projected to be quintessential of healthcare reforms withinside the close to future. Digital fitness and telehealth have taken the front seat withinside the ongoing outbreak. COVID-19 re-emphasized the significance of remote diagnosis, care, and session. Over the few years, regulatory and behavioral boundaries have slowed telehealth increase. However, considering that many healthcare companies are presently running on video conferencing and smartphone calls, the section is predicted to enjoy an increase over the following years. Sufferers with minor symptoms were required to attend online sessions as part of the social distancing strategies. In addition, it substantially decreased the load on hospitals already swamped through counts of COVID-19 sufferers. Medical IoT gadgets that at-domestic sufferers can utilize are getting used for optimizing outpatient remedies and minimizing repeat visits, and those gadgets may be similarly utilized in a disaster. The pandemic brought about extreme aid constraints. This is anticipated to improve aggressive pricing and value-primarily based pricing models, which enhances the increase of AI in the genomics market.
Rise in want to manipulate discovery cost & time for the duration of new drug improvement and growth in private-public area investments in AI in genomics have boosted the boom of the global AI in the genomics marketplace. Furthermore, one of the key factors driving the market's growth is the adoption of AI in the creation of precision medicines.
In current years, governments in numerous countries have made significant investments withinside the discipline of genomics. These investments have performed multiple functions withinside the improvement of recent technologies. Furthermore, customized drug treatments assist scientific experts in becoming aware of the precise affected person desires, after which prescribe remedies and drugs accordingly, which is predicted to contribute to the direction of the marketplace boom.
However, the loss of a professional AI body of workers and ambiguous regulatory tips for scientific software programs restrain the AI in genomics marketplace boom for the duration of the forecast period. Although there are many factors studies reported as d?t? h??t?r???l, t??hn?l?g???l ?nn?v?t??n?, g?v?rnm?nt ??l????? ?nd m?nd?t??, ??m??t?t?v? l?nd?????, New ??lut??n? ?nd ?lt?r?t??n? ?urr?nt ?nd h??t?r???l tr?nd? ?n th? m?rk?t, m?rk?t ?nv?r?nm?nt, t??hn?l?g???l ?dv?n??m?nt? ?n r?l?t?d ?ndu?tr??? and m?rk?t g?wth b?rr??r? And challenges, future scenarios, market opportunities, and risks have been mentioned and detailed in the report.
Major Players in the Market:
The key players operating in the market are IBM, Deep Genomics, Microsoft, NVIDIA Corporation, BenevolentAI, Verge Genomics, and Fabric Genomics Inc.
Recent Innovations in the Global AI in Genomics Market:
- DBT (Department of Biotechnology) launched the GIP (Genome India Project) in January 2020. This assignment is aimed to gather 10,000 genetic samples from Indian citizens.
Artificial Intelligence In Genomics Market Scope
|Forecast Unit||Value (USD)|
|Revenue forecast in 2029||$6.22 billion|
|Growth Rate||CAGR of 42.8% during 2021-2029|
|Segment Covered||by Offering, by Delivery Mode, Regions|
|Regions Covered||North America, Europe, Asia Pacific, South America, Middle East and Africa|
|Key Players Profiled||Microsoft Corporation (U.S.), NVIDIA Corporation (U.S.), Deep Genomics (Canada), Fabric Genomics, Inc. (U.S.), Data4Cure, Inc. (U.S.), Predictive Oncology Inc. (U.S.), Emedgene (U.S.), Congenica Ltd. (U.K.), Tempus (U.S.), SOPHiA GENETICS (Switzerland).|
Key Segments of the Global Artificial Intelligence in Genomics Market
Offering Overview, 2018-2028 (USD Billion)
Technology Overview, 2018-2028 (USD Billion)
- Machine Learning
- Computer Vision
Application Overview, 2018-2028 (USD Billion)
- Genome Sequencing
- Genome Editing
- Genome Mapping
End-User Overview, 2018-2028 (USD Billion)
- Research Bodies
- Pharmaceutical Companies
Region Overview, 2018-2028 (USD Billion)
- United States
- Rest of Europe
- South Korea
- Southeast Asia
- Rest of Asia-Pacific
Middle East & Africa
- Saudi Arabia
- Rest of Middle East & Africa